Cardinal Health (NYSE:CAH) Releases FY25 Earnings Guidance

Cardinal Health (NYSE:CAH - Get Free Report) issued an update on its FY25 earnings guidance on Thursday morning. The company provided EPS guidance of at least $7.50 for the period, compared to the consensus EPS estimate of $7.89. Cardinal Health also updated its FY24 guidance to $7.30-7.40 EPS.

Cardinal Health Stock Up 0.8 %

Shares of NYSE CAH traded up $0.81 during midday trading on Thursday, hitting $102.98. The company had a trading volume of 3,700,991 shares, compared to its average volume of 2,275,163. The business has a 50-day simple moving average of $109.37 and a two-hundred day simple moving average of $104.98. Cardinal Health has a twelve month low of $77.56 and a twelve month high of $116.04. The firm has a market capitalization of $25.05 billion, a price-to-earnings ratio of 40.62, a price-to-earnings-growth ratio of 1.04 and a beta of 0.71.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its quarterly earnings data on Thursday, February 1st. The company reported $1.82 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.56 by $0.26. The firm had revenue of $57.45 billion during the quarter, compared to analysts' expectations of $57.02 billion. Cardinal Health had a negative return on equity of 57.44% and a net margin of 0.30%. Cardinal Health's revenue was up 11.6% on a year-over-year basis. During the same period in the previous year, the firm posted $1.32 earnings per share. On average, equities analysts forecast that Cardinal Health will post 7.28 EPS for the current year.

Cardinal Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, April 15th. Stockholders of record on Monday, April 1st were given a $0.5006 dividend. The ex-dividend date of this dividend was Thursday, March 28th. This represents a $2.00 annualized dividend and a dividend yield of 1.94%. Cardinal Health's dividend payout ratio is presently 78.74%.

Analyst Ratings Changes

Several research analysts recently weighed in on the stock. StockNews.com raised shares of Cardinal Health from a buy rating to a strong-buy rating in a research note on Thursday. Wells Fargo & Company decreased their target price on shares of Cardinal Health from $96.00 to $94.00 and set an underweight rating on the stock in a research report on Monday. Barclays began coverage on Cardinal Health in a report on Wednesday, January 3rd. They issued an overweight rating and a $117.00 price target for the company. UBS Group upped their target price on Cardinal Health from $122.00 to $125.00 and gave the company a buy rating in a research note on Monday, February 5th. Finally, SVB Leerink started coverage on Cardinal Health in a research note on Monday, February 26th. They issued an outperform rating and a $125.00 price target on the stock. One analyst has rated the stock with a sell rating, three have assigned a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, Cardinal Health currently has an average rating of Moderate Buy and a consensus price target of $102.93.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.